BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2807622
Number of visits today
274
Number of downloads
2059309
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Sun Y, Wu J, Yuan Y, Lu Y, Luo M, Lin L, Ma S. Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma. Front Cell Dev Biol 2021;9:673838. [PMID: 34124058 DOI: 10.3389/fcell.2021.673838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hurdogan O, De Logu F, Galli F, Tuncer S, Ugolini F, Simi S, Portelli F, Nassini R, Massi D, Buyukbabani N. Digital Quantification of Intratumoral CD8+ T-Cells Predicts Relapse and Unfavorable Outcome in Uveal Melanoma. Cancers (Basel) 2022;14. [PMID: 36497441 DOI: 10.3390/cancers14235959] [Reference Citation Analysis]
2 Dong H, Xie C, Yao Z, Zhao R, Lin Y, Luo Y, Chen S, Qin Y, Chen Y, Zhang H. PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. Front Immunol 2022;13:947841. [DOI: 10.3389/fimmu.2022.947841] [Reference Citation Analysis]
3 Yu S, Li X, Ma M, Yang R, Zhang J, Wu S. The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer. Cancers (Basel) 2022;14. [PMID: 35626004 DOI: 10.3390/cancers14102399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345